Exact Mass: 327.1365

Exact Mass Matches: 327.1365

Found 76 metabolites which its exact mass value is equals to given mass value 327.1365, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-(1-Deoxy-1-fructosyl)phenylalanine

(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)propanoic acid

C15H21NO7 (327.1318)


Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)phenylalanine is classified as a Natural Food Constituent (code WA) in the DFC.

   

Blood platelet activating factor-acether

(2-{[2-(acetyloxy)-3-ethoxypropyl phosphono]oxy}ethyl)trimethylazanium

C12H26NO7P (327.1447)


   
   

Chondriamide C

Chondriamide C

C21H17N3O (327.1372)


   

3-(5-Isopropyl-3,8-dimethylazulen-1-yl)-2-(methylsulfonyl)acrylonitrile

3-(5-Isopropyl-3,8-dimethylazulen-1-yl)-2-(methylsulfonyl)acrylonitrile

C19H21NO2S (327.1293)


   

Maybridge3_000646

Maybridge3_000646

C21H17N3O (327.1372)


   
   

methyl N-{4-[(alpha-L-rhamnopyranosyl)benzyl]}carbamate

methyl N-{4-[(alpha-L-rhamnopyranosyl)benzyl]}carbamate

C15H21NO7 (327.1318)


   

Domoilactone B

Domoilactone B

C15H21NO7 (327.1318)


   

Trigonostemonine E

Trigonostemonine E

C21H17N3O (327.1372)


   

1-Deoxy-1-L-phenylalanino-D-fructose

1-Deoxy-1-L-phenylalanino-D-fructose

C15H21NO7 (327.1318)


   
   

2-Formyl-komarovicine

NCGC00160300-01!2-Formyl-komarovicine

C21H17N3O (327.1372)


   

N-Fructosyl phenylalanine

N-Fructosyl phenylalanine

C15H21NO7 (327.1318)


Annotation level-3

   

N2-Methylisoeugenolyl-guanine

N2-Methylisoeugenolyl-guanine

C16H17N5O3 (327.1331)


   
   
   

Platelet-activating factor

3,5,9-Trioxa-4-phosphaundecan-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C12H26NO7P (327.1447)


   

PC(4:0/0:0)

3,5,9-Trioxa-4-phosphatridecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

C12H26NO7P (327.1447)


   

PC(0:0/4:0)

3,5,8-Trioxa-4-phosphadodecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (R)-

C12H26NO7P (327.1447)


   

PC(0:0/4:0)[U]

3,5,8-Trioxa-4-phosphadodecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide

C12H26NO7P (327.1447)


   

PC O-4:0

1-ethyl-2-acetyl-sn-glycero-3-phosphocholine

C12H26NO7P (327.1447)


   

LPC 4:0

2-butyryl-sn-glycero-3-phosphocholine

C12H26NO7P (327.1447)


   

5-Amino-N,N-bis(2,3-dihydroxypropyl)isophthalamide

5-Amino-N,N-bis(2,3-dihydroxypropyl)isophthalamide

C14H21N3O6 (327.143)


   
   
   

METHYL2-DEOXY-2-[[(PHENYLMETHOXY)CARBONYL]AMINO]-ALPHA-D-GLUCOPYRANOSIDE

METHYL2-DEOXY-2-[[(PHENYLMETHOXY)CARBONYL]AMINO]-ALPHA-D-GLUCOPYRANOSIDE

C15H21NO7 (327.1318)


   

METHYL 2-FLUORO-3-(PYRROLIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLATE

METHYL 2-FLUORO-3-(PYRROLIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLATE

C19H18FNO3 (327.1271)


   

1,3-Benzenedicarboxamide,5-amino-N1,N3-bis(2,3-dihydroxypropyl)-

1,3-Benzenedicarboxamide,5-amino-N1,N3-bis(2,3-dihydroxypropyl)-

C14H21N3O6 (327.143)


   

N-[(2R,3S)-2-(2,5-Difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamic acid 1,1-dimethylethyl ester

N-[(2R,3S)-2-(2,5-Difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamic acid 1,1-dimethylethyl ester

C16H19F2NO4 (327.1282)


   

1-Butanaminium,N,N-dibutyl-N-methyl-, iodide (1:1)

1-Butanaminium,N,N-dibutyl-N-methyl-, iodide (1:1)

C13H30IN (327.1423)


   

Tenovin-3

Tenovin-3

C18H21N3OS (327.1405)


Tenovin-3 is a p53 activator[1][2].

   

2-amino-N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-sulfonamide

2-amino-N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-sulfonamide

C13H22BN3O4S (327.1424)


   

Tribulus terrestris, ext.

Tribulus terrestris, ext.

C10H21N3O9 (327.1278)


   

1-[2-(Methylsulfonyl)ethyl]-6-oxo-1,6-dihydropyridine-3-boronic Acid Pinacol Ester

1-[2-(Methylsulfonyl)ethyl]-6-oxo-1,6-dihydropyridine-3-boronic Acid Pinacol Ester

C14H22BNO5S (327.1312)


   

N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide

N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide

C14H22BNO5S (327.1312)


   

(1r)-2-Phenylacetamido-2-(3-carboxyphenyl)ethyl boronic acid

(1r)-2-Phenylacetamido-2-(3-carboxyphenyl)ethyl boronic acid

C17H18BNO5 (327.1278)


   

{[2-(5-Methylfuran-2-yl)-1,3-thiazol-4-yl]methyl}(propan-2-yl)[(pyridin-2-yl)methyl]amine

{[2-(5-Methylfuran-2-yl)-1,3-thiazol-4-yl]methyl}(propan-2-yl)[(pyridin-2-yl)methyl]amine

C18H21N3OS (327.1405)


   

2-(2-Hydroxy-biphenyl-3-yl)-1H-indole-5-carboxamidine

2-(2-Hydroxy-biphenyl-3-yl)-1H-indole-5-carboxamidine

C21H17N3O (327.1372)


   

Blood platelet activating factor-acether

Blood platelet activating factor-acether

C12H26NO7P (327.1447)


   
   
   

(2-Acetyloxy-3-ethoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Acetyloxy-3-ethoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C12H26NO7P (327.1447)


   

1-Quinolin-8-yl-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbaldehyde

1-Quinolin-8-yl-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbaldehyde

C21H17N3O (327.1372)


   

3-(2,5-Dimethyl-3-furanyl)-5,6-diphenyl-1,2,4-triazine

3-(2,5-Dimethyl-3-furanyl)-5,6-diphenyl-1,2,4-triazine

C21H17N3O (327.1372)


   

2,5-dioxopyrrolidin-1-yl N2,N6-diacetyllysinate

2,5-dioxopyrrolidin-1-yl N2,N6-diacetyllysinate

C14H21N3O6 (327.143)


   

4-(4-hydroxyphenyl)-N-(phenylmethyl)-1-piperazinecarbothioamide

4-(4-hydroxyphenyl)-N-(phenylmethyl)-1-piperazinecarbothioamide

C18H21N3OS (327.1405)


   

2,2-dimethyl-N-[[4-(pyridin-4-ylmethyl)anilino]-sulfanylidenemethyl]propanamide

2,2-dimethyl-N-[[4-(pyridin-4-ylmethyl)anilino]-sulfanylidenemethyl]propanamide

C18H21N3OS (327.1405)


   
   
   
   

(1S,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide

(1S,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide

C18H18FN3O2 (327.1383)


   

(1S,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide

(1S,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide

C18H18FN3O2 (327.1383)


   

(1R,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide

(1R,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide

C18H18FN3O2 (327.1383)


   

(1R,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide

(1R,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinoline-2-carboxamide

C18H18FN3O2 (327.1383)


   

N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-alaninamide

N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-alaninamide

C13H21N5O3S (327.1365)


   

(3-Butanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Butanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C12H26NO7P (327.1447)


   

3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)-2-hydroxypropyl heptanoate

3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)-2-hydroxypropyl heptanoate

C12H26NO7P (327.1447)


   

N-(1-Deoxy-1-fructosyl)phenylalanine

N-(1-Deoxy-1-fructosyl)phenylalanine

C15H21NO7 (327.1318)


An L-phenylalanine derivative in which one of the amino hydrogens of L-phenylalanine has been replaced by a 1-fructosyl group.

   

1-butyryl-sn-glycero-3-phosphocholine

1-butyryl-sn-glycero-3-phosphocholine

C12H26NO7P (327.1447)


   

2-butyryl-sn-glycero-3-phosphocholine

2-butyryl-sn-glycero-3-phosphocholine

C12H26NO7P (327.1447)


   

GLUT1-IN-2

GLUT1-IN-2

C21H17N3O (327.1372)


GLUT1-IN-2 (compound 17) is a GLUT1 inhibitor with an IC50 value of 12 μM. GLUT1-IN-2 shows inhibitory effect to Plasmodium falciparum hexose transporter PfHT with an IC50 value of 13 μM. GLUT1-IN-2 can be used for the research of infection[1].

   

(e,2e)-3-(1h-indol-3-yl)-n-[(1e)-2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid

(e,2e)-3-(1h-indol-3-yl)-n-[(1e)-2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid

C21H17N3O (327.1372)


   

n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]methoxycarboximidic acid

n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]methoxycarboximidic acid

C15H21NO7 (327.1318)


   

6-hydroxy-4-[(4r,5s,6r)-5-hydroxy-6-[(2s,3r)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[(4r,5s,6r)-5-hydroxy-6-[(2s,3r)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

C15H21NO7 (327.1318)


   

n-[(4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]methoxycarboximidic acid

n-[(4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]methoxycarboximidic acid

C15H21NO7 (327.1318)


   

(2e)-3-(1h-indol-3-yl)-n-[2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid

(2e)-3-(1h-indol-3-yl)-n-[2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid

C21H17N3O (327.1372)


   

3-(carboxymethyl)-4-[(1z)-1-(3-hydroxy-4-methyl-5-oxooxolan-2-yl)prop-1-en-2-yl]pyrrolidine-2-carboxylic acid

3-(carboxymethyl)-4-[(1z)-1-(3-hydroxy-4-methyl-5-oxooxolan-2-yl)prop-1-en-2-yl]pyrrolidine-2-carboxylic acid

C15H21NO7 (327.1318)


   

6-hydroxy-4-[5-hydroxy-6-(2-hydroxy-3-methyl-4-methylideneoxolan-2-yl)-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[5-hydroxy-6-(2-hydroxy-3-methyl-4-methylideneoxolan-2-yl)-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

C15H21NO7 (327.1318)


   

(z,2e)-3-(1h-indol-3-yl)-n-[(1z)-2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid

(z,2e)-3-(1h-indol-3-yl)-n-[(1z)-2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid

C21H17N3O (327.1372)


   

6-hydroxy-4-[(5r,6s)-5-hydroxy-6-[(2r,3r)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[(5r,6s)-5-hydroxy-6-[(2r,3r)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

C15H21NO7 (327.1318)


   

n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)methoxycarboximidic acid

n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)methoxycarboximidic acid

C15H21NO7 (327.1318)


   

3-(1h-indol-3-yl)-n-[2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid

3-(1h-indol-3-yl)-n-[2-(1h-indol-3-yl)ethenyl]prop-2-enimidic acid

C21H17N3O (327.1372)


   

6-hydroxy-4-[(4r,5s,6r)-5-hydroxy-6-[(2r,3r)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[(4r,5s,6r)-5-hydroxy-6-[(2r,3r)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

C15H21NO7 (327.1318)


   

7-methoxy-4-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

7-methoxy-4-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}quinoline

C21H17N3O (327.1372)


   

6-hydroxy-4-[(4r,5s,6r)-5-hydroxy-6-[(2s,3s)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[(4r,5s,6r)-5-hydroxy-6-[(2s,3s)-2-hydroxy-3-methyl-4-methylideneoxolan-2-yl]-1,3-dioxan-4-yl]-4,5-dihydro-3h-pyridin-2-one

C15H21NO7 (327.1318)